Breakthrough in Cancer Treatment: FDA approves CAR-T Immunotherapy


The advisers of US Food and Drug Administration (FDA) gave their nod to CAR-T Immunotherapy for treating different forms of cancers.This therapy genetically engineers the patient’s own immune cells to target the cancerous ones and destroy them.

Reference Link: http://www.nature.com/news/engineered-cell-therapy-for-cancer-gets-thumbs-up-from-fda-advisers-1.22304



Author :
   Editor

.



About Us

Reseapro publishes journals, provides essential resources, and facilitates a host of services. This site is intended for researchers in various domains.



Let's Talk

Do you want to learn more about how I can help your company overcome problems? Let us have a conversation.